BTIG initiates Mondelez stock coverage with buy rating, $70 target By Investing.com

BTIG initiated coverage on Mondelez with a Buy rating and a $70 price target, implying about 20x 24-month EPS and roughly 15x EV/EBITDA. The firm argued the stock's valuation is overly discounted despite Mondelez's branded portfolio, geographic exposure, and asset base; Mondelez also yields 3.39% and has raised its dividend for 12 consecutive years. While the article notes recent caution from other brokers, the net tone on MDLZ is modestly positive and unlikely to drive broad market impact.

Analysis

The key read-through is not just valuation support for MDLZ, but the market signaling that the category’s defensiveness is being re-rated after a period of multiple compression. If branded snacking can sustain even low- to mid-single-digit organic growth with cash conversion intact, the stock should trade more like a quality staple than a cyclical consumer name, which argues for a higher terminal multiple than the current setup implies. The bigger second-order effect is that a stronger MDLZ multiple can pull up the entire global snack/packaged-food complex, especially names with similar emerging-market mix and pricing power.

The earnings debate is increasingly about volume elasticity versus mix and margin durability. If promotion intensity is rolling off, the near-term risk is that unit volumes remain soft for a few quarters, but that can actually improve reported profitability if trade spend was previously inefficient. In that case, the market may be underestimating how quickly EPS can inflect once pricing laps lapses into a cleaner margin stack, particularly into year-end when comparison bars get easier.

The contrarian miss is that consensus may be treating Europe and U.S. snacking as a single demand story when they are really separate operating regimes. Europe looks like the nearer-term swing factor for sentiment, but the bigger buffer is the company’s geographic diversification and cash-return profile, which can absorb regional weakness better than peers. For KHC, this is mildly negative relative to MDLZ because capital can rotate toward the higher-quality balance sheet and more consistent dividend growth story; over time, that widens the valuation gap between branded snack quality and legacy center-aisle packaged food.

Key Decisions for Investors

• Go long MDLZ on pullbacks over the next 2-6 weeks with a 6-12 month horizon; target a rerating toward the low- to mid-20s forward P/E if execution stays intact, with downside limited by dividend support and defensive cash flow.
• Pair trade: long MDLZ / short KHC for 3-9 months to express quality-within-packaged-food dispersion; thesis is multiple expansion for the better-growth, better-capital-return name while KHC remains more exposed to secular volume pressure.
• If options liquidity is sufficient, buy MDLZ call spreads 3-6 months out to capture a rerating catalyst into earnings/guide resets; risk/reward is attractive if the market starts paying up for stability again.
• Trim or avoid chasing the move if MDLZ trades above the implied valuation bridge without confirming volume stabilization; upside from here depends more on maintained guidance than on further multiple expansion.